Search results
Results From The WOW.Com Content Network
Dec. 2—Pfizer Inc. is starting to roll out the pharmaceutical company's biggest round of layoffs since 2009, and its Groton laboratories are not immune. Of course, New York-based Pfizer these ...
Viatris Pharmaceutical Plant in Istanbul. 27 may 2023. The company produces and sells a variety of medicines, with 1,400 approved therapeutic molecules in its portfolio. [ 31 ] It owns brands (like Viagra , Xanax , Lipitor ), [ 6 ] [ 32 ] generics , including branded and complex generics, biosimilars , [ 33 ] [ 34 ] and over-the-counter (OTC ...
The company expects to be profitable in 2025. [ 2 ] In July 2023 due to a disappointing sales ramp-up of the recently approved sleep drug daridorexant , coupled with disappointing trial results in both clazosentan and lucerestat , Idorsia announced layoffs of up to five hundred staff of its one thousand two hundred total employees, to reduce ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Donald Trump's Agenda 47 and the Heritage Foundation's Project 2025 provide plenty of clues into what health-care changes may be coming. ... by brand-name pharmaceutical manufacturers, ...
Pharmaceuticals are a tricky business. Public policy, science, R&D;, global growth and regulation all play a role, sometimes outsize, in the success of pharmaceutical stocks.But some Big Pharma ...
The organization claims that higher prices incentivize research and development, even though pharmaceutical spending on marketing exceeds that spent on research, [7] including off-label promotion that has resulted in settlements in the billions of dollars.
The Centers for Medicare and Medicaid Services (CMS) released its first-ever negotiated drug price list Thursday morning to a muted response on Wall Street. But industry and government officials ...